Could a Super-Dose flu shot save lung transplant patients?

NCT ID NCT05215327

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 31 times

Summary

This study compares a high-dose flu vaccine to the standard dose in 270 lung transplant recipients. The goal is to see if the high-dose shot provides better protection against influenza, which can be very dangerous for these patients. Participants will receive two doses of either vaccine within the same flu season.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.